Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 45
Filter
Add more filters











Publication year range
1.
Acta cir. bras ; Acta cir. bras;30(12): 819-823, Dec. 2015. tab, graf
Article in English | LILACS | ID: lil-769506

ABSTRACT

ABSTRACT PURPOSE: To develop an experimental model of neurocysticercosis-induced hydrocephalus METHODS: There were used 17 rats. Ten animals were inoculated with Taenia crassiceps cysts into the subarachnoid. Five animals were injected with 0.1ml of 25% kaolin (a standard solution for the development of experimental hydrocephalus) and two animals were injected with saline. Magnetic resonance imaging (MRI) was used to evaluate enlargement of the ventricles after one or three months of inoculation. Volumetric study was used to quantify the ventricle enlargement. RESULTS: Seven of the 10 animals in the cyst group developed hydrocephalus, two of them within one month and five within three months after inoculation. Three of the five animals in the kaolin group had hydrocephalus and none in the saline group. Ventricle volumes were significantly higher in the 3-months MRI cyst subgroup than in the 1-month cyst subgroup. Differences between cyst subgroups and kaolin group did not reach statistical significance. CONCLUSION: The developed model may reproduce the human condition of neurocysticercosis-related hydrocephalus, which exhibits a slowly progressive chronic course.


Subject(s)
Animals , Disease Models, Animal , Hydrocephalus/chemically induced , Neurocysticercosis/parasitology , Cerebral Ventricles/drug effects , Cerebral Ventricles/pathology , Kaolin , Magnetic Resonance Imaging , Neurocysticercosis/pathology , Pilot Projects , Rats, Wistar , Taenia
2.
Acta Cir Bras ; 30(12): 819-23, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26735053

ABSTRACT

PURPOSE: To develop an experimental model of neurocysticercosis-induced hydrocephalus METHODS: There were used 17 rats. Ten animals were inoculated with Taenia crassiceps cysts into the subarachnoid. Five animals were injected with 0. ml of 25% kaolin (a standard solution for the development of experimental hydrocephalus) and two animals were injected with saline. Magnetic resonance imaging (MRI) was used to evaluate enlargement of the ventricles after one or three months of inoculation. Volumetric study was used to quantify the ventricle enlargement. RESULTS: Seven of the 10 animals in the cyst group developed hydrocephalus, two of them within one month and five within three months after inoculation. Three of the five animals in the kaolin group had hydrocephalus and none in the saline group. Ventricle volumes were significantly higher in the 3-months MRI cyst subgroup than in the 1-month cyst subgroup. Differences between cyst subgroups and kaolin group did not reach statistical significance. CONCLUSION: The developed model may reproduce the human condition of neurocysticercosis-related hydrocephalus, which exhibits a slowly progressive chronic course.


Subject(s)
Disease Models, Animal , Hydrocephalus/chemically induced , Neurocysticercosis/parasitology , Animals , Cerebral Ventricles/drug effects , Cerebral Ventricles/pathology , Kaolin , Magnetic Resonance Imaging , Neurocysticercosis/pathology , Pilot Projects , Rats, Wistar , Taenia
3.
Mol Neurobiol ; 43(3): 207-14, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21424678

ABSTRACT

An increasing number of studies have evaluated the potential therapeutic relevance of histone deacetylases (HDAC) inhibitors in mood disorder including bipolar disorder (BD). It has been suggested that the anterior limbic, which controls impulsivity and psychosis, is dysfunctional in BD. The present studies aims to evaluate the effects of microinjection of HDAC inhibitors in the ventricle, amygdala, striatum, prefrontal, and hippocampus on m-amphetamine-induced manic-like behavior in rats. Rats were given a single intracerebral (in the ventricle, amygdala, striatum, prefrontal, or hippocampus) injection of artificial cerebrospinal fluid, sodium butyrate (SB), or valproate (VPA) followed by an intraperitoneal injection of saline or m-AMPH 2 h before the open-field task. The activity of HDAC was evaluated in amygdala, striatum, prefrontal, and hippocampus of animals. The microinjection of SB and VPA in the ventricle, amygdala, striatum, and prefrontal, but not in hippocampus blocked the hyperactivity induced by m-AMPH. In addition, SB and VPA inhibited the HDAC activity; however, this effect varied depending on the experimental procedure and the brain structure evaluated. Our results suggest that the antimanic effects of SB and VPA, HDAC inhibitors, are related to the amygdala, striatum, and prefrontal, but not the hippocampus. More studies are needed to clarify the therapeutic effects of the HDAC inhibitor in BD and thereby develop new drugs.


Subject(s)
Antimanic Agents/pharmacology , Histone Deacetylase Inhibitors/pharmacology , Nervous System/anatomy & histology , Nervous System/drug effects , Amygdala/drug effects , Amygdala/physiology , Animals , Butyrates/administration & dosage , Butyrates/pharmacology , Cerebral Ventricles/drug effects , Cerebral Ventricles/physiology , Hippocampus/drug effects , Hippocampus/physiology , Male , Microinjections , Neostriatum/drug effects , Neostriatum/physiology , Prefrontal Cortex/drug effects , Prefrontal Cortex/physiology , Rats , Rats, Wistar , Valproic Acid/administration & dosage , Valproic Acid/pharmacology
4.
Brain Res ; 1317: 246-56, 2010 Mar 04.
Article in English | MEDLINE | ID: mdl-20043888

ABSTRACT

Monosodium glutamate (MSG) subcutaneously administrated to neonatal rats induces several neurochemical alterations in the brain, which have been associated with an excitotoxic process triggered by an over activation of glutamate receptors; however there are few systematic studies about initial changes in intracerebroventricular (i.c.v.) Glu levels produced by MSG in the brain. Thus, to characterize these changes, rat pups were injected with a MSG solution at 1, 3, 5 and 7 postnatal days (PD), and i.c.v. Glu levels and hippocampal total content of related amino acids (Asp, Glu, Gln, Gly, Tau, Ala and GABA) were estimated before, immediately and after each injection. Behavioral and EEG responses were also monitored after MSG administrations. Significant rise in i.c.v. Glu levels were found, mainly in response to the first and second injection. Moreover, the total content of all amino acids evaluated also increased during the first hour after the first MSG administration but only Glu and GABA remained elevated after 24 h. These biochemical modifications were accompanied with behavioral alterations characterized by: screeching, tail stiffness, head nodding, emprosthotonic flexion episodes and generalized tonic-clonic convulsions, which were associated with electroencephalographic pattern alterations. Altered behavior found in animals treated with MSG suggests an initial seizure situation. Although four MSG administrations were used, the most relevant findings were observed after the first and second administrations at PD1 and PD3, suggesting that only two MSG injections could be sufficient to resemble a seizure and/or excitotoxic model.


Subject(s)
Disease Models, Animal , Neurotoxins/toxicity , Seizures/chemically induced , Sodium Glutamate/toxicity , Amino Acids/metabolism , Animals , Animals, Newborn , Biosensing Techniques , Cerebral Ventricles/drug effects , Cerebral Ventricles/metabolism , Electroencephalography , Glutamic Acid/cerebrospinal fluid , Glutamic Acid/metabolism , Hippocampus/drug effects , Hippocampus/physiopathology , Male , Motor Activity/drug effects , Rats , Rats, Wistar , Seizures/physiopathology , Time Factors , gamma-Aminobutyric Acid/metabolism
5.
Brain Res Bull ; 57(5): 613-8, 2002 Mar 15.
Article in English | MEDLINE | ID: mdl-11927363

ABSTRACT

The role of the central nervous system (CNS) in the control of hydrosaline homeostasis has been strikingly demonstrated by several studies. Growing evidence suggests that insulin may exert an influence in the modulation of many brain functions. However, there are no available data examining the CNS effect of insulin injection on renal sodium handling. Also, to examine the influence of renal nerve activity during i.c.v. administration of insulin, unanesthetized, unrestrained rats were randomly assigned to one of nine separated groups: (a) sham-operated i.c.v. 0.15 M NaCl-injected (Co, pooled data, n = 37) and sham-operated i.c.v. 0.42 ng. microl(-1) (n = 12), 4.2 ng.microl(-1) (n = 10) and 42.0 ng.microl(-1) (n = 11) insulin-injected rats (In); (b) renal-denervated i.c.v. 0.15 M NaCl (Co(Dx), n = 5), and insulin-injected rats (In(Dx), n = 5); and (c) subcutaneously insulin-injected rats (SC, n = 5). We showed that centrally administered insulin produced dose-related increased urinary output of sodium [Co: 855 +/- 85 Delta% min, 0.42 ng.microl(-1) In: 1189 +/- 308 Delta% min, 4.2 ng.microl(-1) In: 1461 +/- 594 Delta% min (p = 0.048), and 42.0 ng.microl(-1) In: 2055 +/- 411 Delta% min (p = 0.0001)], and dose-independently increased potassium excretion [Co: 460 +/- 28 Delta% min, 0.42 ng.microl(-1) In: 649 +/- 100 Delta% min (p = 0.016), 4.2 ng.microl(-1) In: 671 +/- 175 Delta% min (p = 0.003), and 42.0 ng.microl(-1) In: 669 +/- 70 Delta% min (p = 0.002)] compared to control. The urinary sodium excretion response to i.c.v. 42 ng.microl(-1) insulin injections were abolished by bilateral renal denervation. In addition, we showed that insulin-induced natriuresis occurred by increasing postproximal tubule sodium rejection (FEPP(Na)), and changed glomerular filtration rate (C(Cr)) at 42.0 ng.microl(-1) (p = 0.023) i.c.v. insulin microinjection but not at smaller insulin dose. The current data suggests that a blunted efferent insulin-sensitive nerve activity from periventricular region may contribute to the inability of renal tubules to handle the hydroelectrolyte balance.


Subject(s)
Brain/metabolism , Cerebral Ventricles/metabolism , Efferent Pathways/metabolism , Insulin/metabolism , Kidney/innervation , Water-Electrolyte Balance/physiology , Animals , Brain/cytology , Brain/drug effects , Cerebral Ventricles/cytology , Cerebral Ventricles/drug effects , Diabetes Complications , Diabetes Mellitus/metabolism , Diabetes Mellitus/physiopathology , Dose-Response Relationship, Drug , Efferent Pathways/cytology , Efferent Pathways/drug effects , Glomerular Filtration Rate/drug effects , Glomerular Filtration Rate/physiology , Hypertension/etiology , Hypertension/metabolism , Hypertension/physiopathology , Injections, Intraventricular , Insulin/pharmacology , Kidney/physiopathology , Kidney Concentrating Ability/drug effects , Kidney Concentrating Ability/physiology , Kidney Tubules/physiology , Male , Rats , Rats, Wistar , Sodium Chloride/pharmacology , Water-Electrolyte Balance/drug effects
6.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;34(6): 815-20, Jun. 2001. graf
Article in English | LILACS | ID: lil-285858

ABSTRACT

In the present study, we investigated the involvement of the brain renin-angiotensin system in the effects of central cholinergic stimulation on blood pressure in conscious, freely moving normotensive rats. In the first step, we determined the effects of intracerebroventricular (icv) choline (50, 100 and 150 µg) on blood pressure. Choline increased blood pressure in a dose-dependent manner. In order to investigate the effects of brain renin-angiotensin system blockade on blood pressure increase induced by choline (150 µg, icv), an angiotensin-converting enzyme inhibitor, captopril (25 and 50 µg, icv), was administered 3 min before choline. Twenty-five µg captopril did not block the pressor effect of choline, while 50 µg captopril blocked it significantly. Our results suggest that the central renin-angiotensin system may participate in the increase in blood pressure induced by icv choline in normotensive rats.


Subject(s)
Animals , Male , Rats , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Blood Pressure/drug effects , Captopril/pharmacology , Cerebral Ventricles/drug effects , Choline/pharmacology , Choline/antagonists & inhibitors , Injections , Injections, Intraventricular , Rats, Sprague-Dawley , Renin-Angiotensin System/drug effects , Renin-Angiotensin System/physiology
7.
Braz J Med Biol Res ; 34(6): 815-20, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11378673

ABSTRACT

In the present study, we investigated the involvement of the brain renin-angiotensin system in the effects of central cholinergic stimulation on blood pressure in conscious, freely moving normotensive rats. In the first step, we determined the effects of intracerebroventricular (icv) choline (50, 100 and 150 microg) on blood pressure. Choline increased blood pressure in a dose-dependent manner. In order to investigate the effects of brain renin-angiotensin system blockade on blood pressure increase induced by choline (150 microg, icv), an angiotensin-converting enzyme inhibitor, captopril (25 and 50 microg, icv), was administered 3 min before choline. Twenty-five microg captopril did not block the pressor effect of choline, while 50 microg captopril blocked it significantly. Our results suggest that the central renin-angiotensin system may participate in the increase in blood pressure induced by icv choline in normotensive rats.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/pharmacology , Blood Pressure/drug effects , Captopril/pharmacology , Cerebral Ventricles/drug effects , Choline/pharmacology , Animals , Choline/antagonists & inhibitors , Injections , Injections, Intraventricular , Male , Rats , Rats, Sprague-Dawley , Renin-Angiotensin System/drug effects , Renin-Angiotensin System/physiology
8.
Am J Physiol Regul Integr Comp Physiol ; 280(2): R448-57, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11208574

ABSTRACT

We have recently reported that the central heme oxygenase (HO) pathway has an important role in the genesis of lipopolysaccharide fever. However, the HO product involved, i.e., biliverdine, free iron, or carbon monoxide (CO), has not yet been identified with certainty. Therefore, in the present study, we tested the thermoregulatory effects of all HO products. Body core temperature (T(c)) and gross activity of awake, freely moving rats was measured by biotelemetry. Intracerebroventricular administration of heme-lysinate (152 nmol), which induces the HO pathway, evoked a marked increase in T(c), a response that was attenuated by intracerebroventricular pretreatment with the HO inhibitor zinc deuteroporphyrin 2,4-bis glycol (200 nmol), indicating that an HO product has a pyretic action in the central nervous system (CNS) of rats. Besides, heme-lysinate also increased gross activity, but no correlation was found between this effect and the increase in T(c). Moreover, intracerebroventricular biliverdine or iron salts at 152 nmol, a dose at which heme-lysinate was effective in increasing T(c), produced no change in T(c). Accordingly, intracerebroventricular treatment with the iron chelator deferoxamine elicited no change in basal T(c) and did not affect heme-induced pyresis. However, heme-induced pyresis was completely prevented by the soluble guanylate cyclase (sGC) inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a]quinoxaline-1-one. Because biliverdine and iron had no thermoregulatory effects and CO produces most of its actions via sGC, these data strongly imply that CO is the only HO product with a pyretic action in the CNS.


Subject(s)
Carbon Dioxide/physiology , Deuteroporphyrins/pharmacology , Fever/physiopathology , Heme Oxygenase (Decyclizing)/metabolism , Animals , Biliverdine/administration & dosage , Biliverdine/pharmacology , Body Temperature Regulation , Brain/drug effects , Brain/metabolism , Cerebral Ventricles/drug effects , Cerebral Ventricles/physiology , Deferoxamine/pharmacology , Deuteroporphyrins/administration & dosage , Enzyme Inhibitors/administration & dosage , Enzyme Inhibitors/pharmacology , Escherichia coli , Fever/chemically induced , Heme Oxygenase (Decyclizing)/antagonists & inhibitors , Injections, Intraventricular , Iron/metabolism , Lipopolysaccharides/toxicity , Male , Oxadiazoles/pharmacology , Quinoxalines/pharmacology , Rats , Rats, Wistar
9.
Depress Anxiety ; 12(2): 99-101, 2000.
Article in English | MEDLINE | ID: mdl-11091933

ABSTRACT

Corticotropin-releasing hormone (CRH) is anxiogenic when microinjected into the dorsal periaqueductal gray (DPAG). Microinjection of alpha-helical-CRH9-41 (0.5 microgram), a CRH receptor antagonist, however, failed to change anxiety levels. The objective of this study was to verify if this compound has any effect in the anxiogenic behavior of rats submitted to 4 hr of restraint stress 24 hr before the test in an elevated plus maze. Results showed that stressed rats had a decreased exploration of open arms without changing the number of enclosed arm entries. The stress effect was reversed by intra-DPAG injection of alpha-helical-CRH9-41 (0.5 microgram). These results suggest that the anxiogenic behavior of rats previously stressed by forced immobilization might involve facilitation of CRH-mediated neurotransmission in the DPAG.


Subject(s)
Anxiety Disorders/metabolism , Cerebral Ventricles/drug effects , Corticotropin-Releasing Hormone/pharmacology , Peptide Fragments/pharmacology , Periaqueductal Gray/drug effects , Periaqueductal Gray/metabolism , Receptors, Corticotropin-Releasing Hormone/antagonists & inhibitors , Animals , Behavior, Animal/drug effects , Exploratory Behavior/drug effects , Injections, Intraventricular , Maze Learning/drug effects , Microinjections , Neural Conduction/drug effects , Peptide Fragments/drug effects , Rats , Rats, Wistar
10.
Rev Neurol ; 28(7): 665-8, 1999.
Article in Spanish | MEDLINE | ID: mdl-10363290

ABSTRACT

INTRODUCTION AND OBJECTIVE: It is well known that in aged animals cognitive deficit occurs, homologous with that occurring in Alzheimer's disease in humans, and as has been shown in others species, this may be attenuated by administration of nerve growth factor (NGF). Therefore the basic aim of this study was to make an electrophysiological evaluation of the repercussion that there might be after long-term administration of this neurotropin in the sacred baboon (Papio hamadryas) comparing aged with young animals. MATERIAL AND METHODS: We studied a six year old male and a 39 year old female, after sedation. Long-term intraventricular administration of NGF was carried out using a continuous infusion pump, at a dose of 2.1 micrograms/kg/day. Recordings were made before installing the pump and 1, 3 and 6 months after insertion. A Neuropack Four-mini set for evoked potentials (Nihon Kohden) was used to record auditory evoked potentials from the brain stem and visual evoked potentials due to flash. RESULTS AND CONCLUSION: In both animals there were modifications of their electrophysiological responses. These reached a maximum after one month, more markedly in the older animal and this could possibly be related to the neuromodulator effect of NGF.


Subject(s)
Brain/metabolism , Cerebral Ventricles/drug effects , Evoked Potentials , Nerve Growth Factors/pharmacokinetics , Animals , Drug Administration Routes , Female , Follow-Up Studies , Infusion Pumps , Male , Nerve Growth Factors/administration & dosage , Papio/physiology , Time Factors , Tomography, Emission-Computed, Single-Photon
11.
Neuropeptides ; 33(2): 181-8, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10657489

ABSTRACT

This study investigates the effects of intracerebroventricular injection of selective agonists and antagonists of tachykinin NK(3)receptor on performance of mice in the elevated plus-maze test. Mice were treated with either vehicle or 1, 10, 100 or 500 pmol of neurokinin B or senktide ([succinil-Asp(6), MePhe(8)]substance P(6-11), a natural and synthetic selective NK(3)receptor agonists, respectively. Other mice received similar doses of [Trp(7)beta-Ala(8)]NKA(4-10)or SR 142801 ((S)-N-(1-(3-(1-benzoyl-3-(3, 4-dichlorophenyl)-piperidin-3-yl)propyl)-4-phenyl-piperidin- 4-yl)-N-m ethylacetamide) tachykinin NK(3)receptor selective peptide and non-peptide antagonists, respectively. Senktide significantly increased the frequency of entries and the time spent in the open arms, which is compatible with an anxiolytic action. Neurokinin B treatment did not alter the plus-maze parameters in a significant way. Conversely, the NK(3)peptide antagonist [Trp(7)beta-Ala(8)]NKA(4-10), but not SR142801 non-peptide antagonist, showed a reverse effect, i.e. an anxiogenic profile of action, reducing the frequency and the time spent in the open arms. Co-injection of either senktide plus [Trp(7)beta-Ala(8)]NKA((4-10)), or senktide plus SR 142801, blocked the effects promoted by senktide, indicating that centrally-administered NK(3)receptor agonists and antagonists can modulate experimental anxiety.


Subject(s)
Anxiety/physiopathology , Maze Learning/physiology , Neurokinin A/analogs & derivatives , Neurokinin B/pharmacology , Peptide Fragments/pharmacology , Piperidines/pharmacology , Receptors, Neurokinin-3/physiology , Substance P/analogs & derivatives , Tachykinins/physiology , Animals , Cerebral Ventricles/drug effects , Cerebral Ventricles/physiology , Injections, Intraventricular , Male , Maze Learning/drug effects , Mice , Neurokinin A/administration & dosage , Neurokinin A/pharmacology , Neurokinin B/administration & dosage , Peptide Fragments/administration & dosage , Piperidines/administration & dosage , Receptors, Neurokinin-3/agonists , Receptors, Neurokinin-3/antagonists & inhibitors , Substance P/administration & dosage , Substance P/pharmacology
12.
Gen Pharmacol ; 31(4): 583-8, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9792219

ABSTRACT

1. The present studies evaluated the participation of central muscarinic receptors in the cardiovascular effects of centrally injected neostigmine, a quaternary anticholinesterase, in conscious, sham-operated rats and in sinoaortic denervated animals. 2. The dose-dependent pressor effect of neostigmine (0.1 to 1 microg i.c.v.) was greater in sinoaortic denervated rats than in sham-operated animals, but only a dose-dependent bradycardic effect was seen in sham-operated rats. 3. Doses of 3.3 nmol (i.c.v.) of both the M1 muscarinic antagonist, pirenzepine, and the M3 muscarinic antagonist, 4-DAMP, prevented the pressor response to 1 microg of neostigmine in sham-operated rats and in sinoaortic denervated animals; however, the M2 muscarinic antagonist, AF-DX116, partially blocked this response in sham-operated rats while failing to do so in sinoaortic denervated rats. In sham rats, doses of 3.3 nmol (i.c.v.) of both pirenzepine and 4-DAMP prevented the bradycardic response to 1 microg (i.c.v.) of neostigmine, whereas AF-DX116 induced a partial blockade. 4. 4-DAMP, at the dose of 0.3 nmol (i.c.v.), but not pirenzepine at the same dose, prevented the pressor effect of neostigmine (0.1 to 1 microg i.c.v.) in both groups of rats. Both muscarinic antagonists at this dose prevented the bradycardia elicited by the anticholinesterase (0.1 to 1 microg i.c.v.), but 4-DAMP showed a greater antagonistic action on this cardiac effect than pirenzepine. In sham-operated rats, i.c.v. injection of 0.3 nmol of AF-DX116 failed to modify the cardiovascular responses to 0.3 microg of neostigmine. 5. Results suggest mainly an involvement of brain M3-subtype muscarinic receptors in the cardiovascular effect of intracerebroventricular administration of anticholinesterase neostigmine in both groups of rats.


Subject(s)
Cardiovascular System/drug effects , Cerebral Ventricles/drug effects , Neostigmine/pharmacology , Receptors, Muscarinic/drug effects , Receptors, Muscarinic/physiology , Animals , Blood Pressure/drug effects , Cholinergic Agents/pharmacology , Cholinesterase Inhibitors/pharmacology , Female , Heart Rate/drug effects , Male , Muscarinic Antagonists/pharmacology , Neostigmine/administration & dosage , Parasympathectomy , Pirenzepine/pharmacology , Rats , Receptors, Muscarinic/classification , Sinus of Valsalva/drug effects
13.
Am J Physiol ; 275(4): R937-41, 1998 10.
Article in English | MEDLINE | ID: mdl-9756520

ABSTRACT

It has been reported that arginine vasopressin (AVP) plays a thermoregulatory action, but very little is known about the mechanisms involved. In the present study, we tested the hypothesis that nitric oxide (NO) plays a role in systemic AVP-induced hypothermia. Rectal temperature was measured before and after AVP, AVP blocker, or NG-nitro-L-arginine methyl ester (L-NAME; NO synthase inhibitor) injection. Control animals received saline injections of the same volume. The basal body temperature (Tb) measured in control animals was 36.53 +/- 0.08 degreesC. We observed a significant (P < 0.05) reduction in Tb to 35.44 +/- 0.19 degreesC after intravenous injection of AVP (2 micrograms/kg) and to 35.74 +/- 0. 10 degreesC after intravenous injection of L-NAME (30 mg/kg). The systemic injection of the AVP blocker [beta-mercapto-beta, beta-cyclopentamethylenepropionyl1,O-Et-Tyr2,Val4,Arg8]vasopressin (10 micrograms/kg) caused a significant increase in Tb to 37.33 +/- 0.23 degreesC, indicating that AVP plays a tonic role by reducing Tb. When the treatments with AVP and L-NAME were combined, systemically injected L-NAME blunted AVP-induced hypothermia. To assess the role of central thermoregulatory mechanisms, a smaller dose of L-NAME (1 mg/kg) was injected into the third cerebral ventricle. Intracerebroventricular injection of L-NAME caused an increase in Tb, but when intracerebroventricular L-NAME was combined with systemic AVP injection (2 micrograms/kg), no change in Tb was observed. The data indicate that central NO plays a major role mediating systemic AVP-induced hypothermia.


Subject(s)
Arginine Vasopressin/physiology , Body Temperature Regulation/physiology , Body Temperature/physiology , Cerebral Ventricles/physiology , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide/physiology , Animals , Arginine Vasopressin/analogs & derivatives , Arginine Vasopressin/pharmacology , Body Temperature/drug effects , Body Temperature Regulation/drug effects , Cerebral Ventricles/drug effects , Hormone Antagonists/pharmacology , Hypothermia, Induced , Injections, Intraventricular , Male , NG-Nitroarginine Methyl Ester/administration & dosage , Rats , Rats, Wistar
14.
Braz J Med Biol Res ; 31(6): 805-10, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9698827

ABSTRACT

We have previously demonstrated that acute third ventricle injections of both lead and cadmium prevent the dipsogenic response elicited by dehydration or by central injections of dipsogenic agents such as angiotensin II, carbachol and isoproterenol in rats. We have also shown that the antidipsogenic action of cadmium may be due, at least in part, to activation of thirst-inhibitory central serotonergic pathways. In the present paper we show that in Wistar male rats the antidipsogenic effect of both lead acetate (3.0 nmol/rat) and cadmium chloride (3.0 nmol/rat) may be partially dependent on the activation of brain opiatergic pathways since central injections of naloxone (82.5 nmol/rat), a non-selective opioid antagonist, blunt the thirst-inhibiting effect of these metals. One hundred and twenty minutes after the second third ventricle injections, dehydrated animals (14 h overnight) receiving saline + sodium acetate displayed a high water intake (7.90 +/- 0.47 ml/100 g body weight) whereas animals receiving saline + lead acetate drank 3.24 +/- 0.47 ml/100 g body weight. Animals receiving naloxone + lead acetate drank 6.94 +/- 0.60 ml/100 g body weight. Animals receiving saline + saline drank 8.16 +/- 0.66 ml/100 g body weight whilst animals receiving saline + cadmium chloride drank 1.63 +/- 0.37 ml/100 g body weight. Animals receiving naloxone + cadmium chloride drank 8.01 +/- 0.94 ml/100 g body weight. It is suggested that acute third ventricle injections of both lead and cadmium exert their antidipsogenic effect by activating thirst-inhibiting opioid pathways in the brain.


Subject(s)
Cadmium/antagonists & inhibitors , Cerebral Ventricles/drug effects , Drinking/drug effects , Lead/antagonists & inhibitors , Narcotics/pharmacology , Animals , Cadmium/pharmacology , Lead/pharmacology , Male , Naloxone/pharmacology , Narcotic Antagonists/pharmacology , Rats , Rats, Wistar
15.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;31(6): 805-10, jun. 1998. tab, graf
Article in English | LILACS | ID: lil-210970

ABSTRACT

We have previously demonstrated that acute third ventricle injections of both lead and cadmium prevent the dipsogenic response elicited by dehydration or by central injections of dipsogenic agents such as angiotensin II, carbachol and isoproterenol in rats. We have also shown that the antidipsogenic action of cadmium may be due, at least in part, to activation of thirst-inhibitory central serotonergic pathways. In the present paper we show that in Wistar male rats the antidipsogenic effect of both lead acetate (3.0 nmol/rat) and cadmium chloride (3.0 nmol/rat) may be partially dependent on the activation of brain opiatergic pathways since central injections of naloxone (82.5 nmol/rat), a non-selective opioid antagonist, blunt the thirst-inhibiting effect of these metals. One hundred and twenty minutes after the second third ventricle injections, dehydrated animals (14 h overnight) receiving saline + sodium acetate displayed a high water intake (7.90 ñ 0.47 ml/100 g body weight) whereas animals receiving saline + lead acetate drank 3.24 ñ 0.47 ml/100 g body weight. Animals receiving naloxone + lead acetate drank 6.94 ñ 0.60 ml/100 g body weight. Animals receiving saline + saline drank 8.16 ñ 0.66 ml/100 g body weight whilst animals receiving saline + cadmium chloride drank 1.63 ñ 0.37 ml/100 g body weight. Animals receiving naloxone + cadmium chloride drank 8.01 ñ 0.94 ml/100 g body weight. It is suggested that acute third ventricle injections of both lead and cadmium exert their antidipsogenic effect by activating thirst-inhibiting opioid pathways in the brain


Subject(s)
Animals , Male , Rats , Cadmium/antagonists & inhibitors , Cerebral Ventricles/drug effects , Drinking/drug effects , Lead/antagonists & inhibitors , Narcotics/pharmacology , Cadmium/pharmacology , Lead/pharmacology , Naloxone/pharmacology , Narcotic Antagonists/pharmacology , Rats, Wistar
17.
Rev Neurol ; 25(142): 850-5, 1997 Jun.
Article in Spanish | MEDLINE | ID: mdl-9244612

ABSTRACT

The animal model of aged monkeys is a good homologue of Alzheimer's disease in humans, in which it has been shown that there is disproportionate slowing of the EEG when compared with healthy subjects paired for age. This is found both on the conventional EEG and quantitatively. In the latter, relative energy has been the measurement most commonly used for diagnosis and follow-up with various treatments. The follow-up parameters evaluated in this study were: absolute and relative energy of the quantitative EEG (EEGq) obtained in an aged (39 year old) baboon (Papio hamadryas) before and after infusion of intraventricular nerve growth factor (NGF). These findings were compared with those of a young animal (6 year old) of the same species, treated in the same way. Since the animals were first anaesthetized with ketamine and diacepam so as to be able to carry out the study, we used a cerebral function analyzer which allowed us to ascertain that the changes found on analysis of the EEGq were not due to the depth of anaesthesia. The analyzer evaluated the tendencies of amplitude and frequency of the EEG, which is a method widely used for the indirect evaluation of the level of anaesthesia.


Subject(s)
Aging , Brain/pathology , Brain/physiology , Cerebral Ventricles/drug effects , Electroencephalography , Nerve Growth Factors/pharmacology , Alzheimer Disease/diagnosis , Alzheimer Disease/pathology , Animals , Brain Mapping , Follow-Up Studies , Injections, Intraventricular , Nerve Growth Factors/administration & dosage , Papio
18.
Braz J Med Biol Res ; 30(4): 493-6, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9251770

ABSTRACT

We investigated the effects of losartan, an AT1-receptor blocker, and ramipril, a converting enzyme inhibitor, on the pressor response induced by angiotensin II (ANG II) and carbachol (a cholinergic receptor agonist). Male Holtzman rats (250-300 g) with a stainless steel cannula implanted into the lateral ventricle (LV) were used. The injection of losartan (50 nmol/1 microliter) into the LV blocked the pressor response induced by ANG II (12 ng/1 microliter) and carbachol (2 nmol/1 microliter). After injection of ANG II and carbachol into the LV, mean arterial pressure (MAP) increased to 31 +/- 1 and 28 +/- 2 mmHg, respectively. Previous injection of losartan abolished the increase in MAP induced by ANG II and carbachol into the LV (2 +/- 1 and 5 +/- 2 mmHg, respectively). The injection of ramipril (12 ng/1 microliter) prior to carbachol blocked the pressor effect of carbachol to 7 +/- 3 mmHg. These results suggest an interaction between central cholinergic pathways and the angiotensinergic system in the regulation of arterial blood pressure.


Subject(s)
Angiotensin Receptor Antagonists , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Blood Pressure/drug effects , Carbachol/pharmacology , Cerebral Ventricles/drug effects , Cholinergic Agonists/pharmacology , Losartan/pharmacology , Pressoreceptors/drug effects , Ramipril/pharmacology , Renin-Angiotensin System/physiology , Animals , Male , Rats , Rats, Sprague-Dawley
19.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;30(4): 493-6, Apr. 1997. graf
Article in English | LILACS | ID: lil-191387

ABSTRACT

We investigated the effects of losartan, an AT1-receptor blocker, and ramipril, a converting enzyme inhibitor, on the pressor response induced by angiotensin II (ANG II) and carbachol (a cholinergic receptor agonist). Male Holtzman rats (250-300 g) with a stainless steel cannula implanted into the lateral ventricle (LV) were used. The injection of losartan (50 nmol/l mul) into the LV blocked the pressor response induced by ANG II (12 ng/1 mul) and carbachol (2 nmol/ 1 mul). After injection of ANG II and carbachol into the LV, mean arterial pressure (MAP) increased to 31 + 1 and 28 + 2 mmHg, respectively. Previous injection of losartan abolished the increase in MAP induced by ANG II and carbachol into the LV (2 + 1 and 5 + 2 mmHg, respectively). The injection of ramipril (12 ng/ 1 mul) prior to carbachol blocked the pressor effect of carbachol to 7 + 3 mmHg. These results suggests an interaction between central cholinergic pathways and the angiotensinergic system in the regulation of arterial blood pressure.


Subject(s)
Rats , Animals , Male , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Blood Pressure/physiology , Carbachol/pharmacology , Cerebral Ventricles/drug effects , Cholinergic Agonists/pharmacology , Imidazoles/pharmacology , Pressoreceptors/drug effects , Ramipril/pharmacology , Receptors, Angiotensin/antagonists & inhibitors , Renin-Angiotensin System/physiology , Rats, Sprague-Dawley
20.
Braz J Med Biol Res ; 30(3): 419-23, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9246242

ABSTRACT

We have previously demonstrated that acute third ventricle injections of both Pb2+ and Cd2+ impair the dipsogenic response elicited by three different situations: dehydration and central cholinergic or angiotensinergic stimulation. beta-Adrenergic activation is part of the multifactorial integrated systems operating in drinking behavior control in the central nervous system. In the present study acute third ventricle injections of Pb2+ (3, 30 and 300 pmol/rat) or Cd2+ (0.3, 3 and 30 pmol/ rat) blocked the dipsogenic response induced by third ventricle injections of isoproterenol (ISO; 160 nmol/rat) in a dose-dependent manner. Normohydrated animals receiving ISO + NaAc (sodium acetate) or saline (controls) displayed a high water intake after 120 min (ISO+saline = 5.78 +/- 0.54 ml/100 g; ISO+NaAc = 6.00 +/- 0.6 ml/100 g). After the same period, animals receiving ISO but pretreated with PbAc at the highest dose employed (300 pmol/rat) drank 0.78 +/- 0.23 ml/100 g while those receiving ISO and pretreated with the highest dose of CdCl2 (30 pmol/rat) presented a water intake of 0.7 +/- 0.30 ml/100 g. Third ventricle injections of CdCl2 (3 nmol/rat) or PbAc (3 nmol/rat) did not modify food intake in rats deprived of food for 24 h. Thus, general central nervous system depression explaining the antidipsogenic action of the metals can be safely excluded. It is concluded that both Pb2+ and Cd2+ inhibit water intake induced by central beta-adrenergic stimulation.


Subject(s)
Adrenergic beta-Antagonists/pharmacology , Cadmium/pharmacology , Cerebral Ventricles/drug effects , Drinking/drug effects , Isoproterenol/antagonists & inhibitors , Lead/pharmacology , Animals , Male , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL